BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25044256)

  • 1. High early cardiovascular mortality after liver transplantation.
    VanWagner LB; Lapin B; Levitsky J; Wilkins JT; Abecassis MM; Skaro AI; Lloyd-Jones DM
    Liver Transpl; 2014 Nov; 20(11):1306-16. PubMed ID: 25044256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME
    Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score.
    VanWagner LB; Ning H; Whitsett M; Levitsky J; Uttal S; Wilkins JT; Abecassis MM; Ladner DP; Skaro AI; Lloyd-Jones DM
    Hepatology; 2017 Dec; 66(6):1968-1979. PubMed ID: 28703300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular mortality in liver and kidney transplant recipients: A retrospective analysis from a single institution.
    Sertić Z; Letilović T; Kanižaj TF; Knotek M; Hadžibegović I; Starovečki I; Jerkić H
    Medicine (Baltimore); 2021 May; 100(20):e26019. PubMed ID: 34011105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Liver Graft Recipient Workup in Predicting of Early Cardiovascular Events During Liver Transplantation: A Single-Center Experience.
    Raszeja-Wyszomirska J; Glowczynska R; Kostrzewa K; Janik M; Zygmunt M; Zborowska H; Krawczyk M; Niewinski G; Galas M; Krawczyk M; Zieniewicz K; Milkiewicz P; Opolski G
    Transplant Proc; 2018 Sep; 50(7):1997-2001. PubMed ID: 30177096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.
    Schlegel A; Kalisvaart M; Scalera I; Laing RW; Mergental H; Mirza DF; Perera T; Isaac J; Dutkowski P; Muiesan P
    J Hepatol; 2018 Mar; 68(3):456-464. PubMed ID: 29155020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with mortality within 24h of liver transplantation: An updated analysis of 65,308 adult liver transplant recipients between 2002 and 2013.
    Fukazawa K; Pretto EA; Nishida S; Reyes JD; Gologorsky E
    J Clin Anesth; 2018 Feb; 44():35-40. PubMed ID: 29100021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Croome KP; Lee DD; Keaveny AP; Taner CB
    Transplantation; 2016 Dec; 100(12):2640-2647. PubMed ID: 27861295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
    Angelico M; Nardi A; Romagnoli R; Marianelli T; Corradini SG; Tandoi F; Gavrila C; Salizzoni M; Pinna AD; Cillo U; Gridelli B; De Carlis LG; Colledan M; Gerunda GE; Costa AN; Strazzabosco M;
    Dig Liver Dis; 2014 Apr; 46(4):340-7. PubMed ID: 24411484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation.
    VanWagner LB; Montag S; Zhao L; Allen NB; Lloyd-Jones DM; Das A; Skaro AI; Hohmann S; Friedewald JJ; Levitsky J
    Transplantation; 2018 Jul; 102(7):1096-1107. PubMed ID: 29557907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
    Dad T; Tighiouart H; Joseph A; Bostom A; Carpenter M; Hunsicker L; Kusek JW; Pfeffer M; Levey AS; Weiner DE
    Am J Kidney Dis; 2016 Aug; 68(2):277-286. PubMed ID: 26947217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific prediction of ESRD after liver transplantation.
    Sharma P; Goodrich NP; Schaubel DE; Guidinger MK; Merion RM
    J Am Soc Nephrol; 2013 Dec; 24(12):2045-52. PubMed ID: 24029423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalizations for Cardiovascular Disease After Liver Transplantation in the United States.
    Khurmi NS; Chang YH; Eric Steidley D; Singer AL; Hewitt WR; Reddy KS; Moss AA; Mathur AK
    Liver Transpl; 2018 Oct; 24(10):1398-1410. PubMed ID: 29544033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity.
    Gayowski T; Marino IR; Singh N; Doyle H; Wagener M; Fung JJ; Starzl TE
    Transplantation; 1998 Feb; 65(4):499-504. PubMed ID: 9500623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years.
    Koshy AN; Gow PJ; Han HC; Teh AW; Jones R; Testro A; Lim HS; McCaughan G; Jeffrey GP; Crawford M; Macdonald G; Fawcett J; Wigg A; Chen JWC; Gane EJ; Munn SR; Clark DJ; Yudi MB; Farouque O
    Eur Heart J Qual Care Clin Outcomes; 2020 Oct; 6(4):243-253. PubMed ID: 32011663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol.
    Pita-Fernández S; Pértega-Díaz S; Valdés-Cañedo F; Seijo-Bestilleiro R; Seoane-Pillado T; Fernández-Rivera C; Alonso-Hernández A; Lorenzo-Aguiar D; López-Calvino B; López-Muñiz A
    BMC Cardiovasc Disord; 2011 Jan; 11():2. PubMed ID: 21639867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.